The Molecular Jackhammer Cancer Therapeutics Institute is a nonprofit organization that supports the research and development of molecular jackhammers to accelerate the journey toward clinical trials for cancer eradication
Our Values
These core values guide our mission and shape our approach to therapeutic development.
- Innovation & Scientific Excellence
We prioritize cutting-edge research and development, driving innovation to advance molecular jackhammer technology for cancer treatment.
- Patient-Centered Focus
Our mission is rooted in improving patient outcomes. Every decision and effort we make is aimed at bringing life-saving therapeutics closer to clinical use.
- Collaboration & Partnerships
We believe breakthroughs are achieved through teamwork. We foster strong collaborations with researchers, clinicians, and organizations to accelerate our mission.
- Integrity & Transparency
We operate with honesty and openness, ensuring ethical research practices, responsible stewardship of resources.
- Urgency & Determination
Time is critical in the fight against cancer. We act with a sense of urgency, relentless determination, and dedication to eradicating cancer through innovative therapies.
- Education & Awareness
We are committed to raising awareness of our therapeutic advancements and educating the public and scientific community about our mission and progress.
- Inclusivity & Accessibility
We strive to ensure that future molecular jackhammer therapies are developed with equitable access in mind, addressing the needs of diverse patient populations.
Our History
A journey of innovation and dedication in therapeutic development.
Initial Discovery
Initial discovery of Molecular Jackhammers.
Nature Chemistry Publication
Publication of Molecular Jackhammer technology in Nature Chemistry, garnering worldwide attention.
Technology Enhancement & Universal Cancer Treatment
Development of improved and more potent Molecular Jackhammers, which demonstrated to be effective against all tested cancers.
Institute Establishment
Establishment of the Molecular Jackhammers Cancer Therapeutics Institute.